Centrinone-B
CAS No. 1798871-31-4
Centrinone-B ( —— )
产品货号. M33313 CAS No. 1798871-31-4
Centrinone-B (LCR-323) 是一种有效的,高度选择性的 PLK4 抑制剂,Ki 值为 0.59 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥854 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Centrinone-B
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Centrinone-B (LCR-323) 是一种有效的,高度选择性的 PLK4 抑制剂,Ki 值为 0.59 nM。
-
产品描述Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM.
-
体外实验Centrinone-B (LCR-323) is a potent and highly selective PLK4 inhibitor, with a Ki of 0.59 nM. Centrinone-B slightly binds to Aurora A and Aurora B, with Kis of 1239 nM and 5597.14 nM. Centrinone-B (LCR-323) exhibits >1000-fold selectivity for Plk4 over Aurora A/B in vitro and does not affect cellular Aurora A or B substrate phosphorylation at concentrations that deplete centrosomes. Centrinone-B (LCR-323) (0-200 nM) significantly decreases cell viability of PLK4-centriole conjunction melanoma cell lines except p53 mutant SK-MEL-28, and this effect is via inhibition of PLK4. Inhibition of PLK4 by Centrinone-B (LCR-323) also induces apoptosis in human melanoma cell lines.
-
体内实验——
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点PLK
-
受体PLK
-
研究领域——
-
适应症——
化学信息
-
CAS Number1798871-31-4
-
分子量631.67
-
分子式C27H27F2N7O5S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 25 mg/mL (39.58 mM; 超声助溶 )
-
SMILESCOc1c(Nc2cc(C)[nH]n2)nc(Sc2ccc(cc2F)S(=O)(=O)Cc2cccc(c2F)[N+]([O-])=O)nc1N1CCCCC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Wong YL, et al. Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4. Science. 2015 Jun 5;348(6239):1155-60.?
产品手册
关联产品
-
Ilexsaponin A1
Ilexsaponin A 通过抗凋亡途径对缺血再灌注引起的心肌损伤具有保护作用。
-
T521
T521 is a selective inhibitor of the PBD of Plk1 and shows no inhibitory effect on Plk2 and Plk3.
-
CFI-400945
CFI-400945 是一种有效的、选择性的、口服活性的 polo 样激酶 4(PLK4;Ki 值为 0.26 nM)抑制剂。
021-51111890
购物车()
sales@molnova.cn

